Figure 9. Correlation between the ICDscore and anti-tumor immunotherapy. (A) Correlation analysis between the ICDscore and the status of anti-cancer immunity. (B–G) The expression levels of CD274, PDCD1, LAG3, CTLA4, HAVCR2, and TIGIT in UVM patients in the high-ICDscore and the low-ICDscore subgroups of the TCGA-UVM cohort. (H) TIDE score and immunotherapy response rate of UVM patients from TCGA-UVM cohort. (I) Immunotherapy response rate of UVM patients from TCGA-UVM cohort with high-ICDscore and low-ICDscore. Abbreviation: Ns: not significant. *p < 0.05; **p < 0.01; ***p < 0.001.